|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
on1003260372 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
170909s2017 nyu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d NLE
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d SXB
|
| 020 |
|
|
|a 9781119356165
|
| 020 |
|
|
|a 1119356164
|
| 035 |
|
|
|a (OCoLC)1003260372
|
| 050 |
|
4 |
|a HD9665.5
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Reklaitis, Gintaras.
|
| 245 |
1 |
0 |
|a Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture.
|
| 260 |
|
|
|a New York :
|b American Institute of Chemical Engineers,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (419 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Title Page; Copyright Page; Contents; List of Contributors; Preface; Chapter 1 Introduction; 1.1 Quality by Design Overview; 1.2 Pharmaceutical Industry; 1.3 Quality by Design Details; 1.4 Chapter Summaries; References; Chapter 2 An Overview of the Role of Mathematical Models in Implementation of Quality by Design Paradigm for Drug Development and Manufacture ; 2.1 Introduction; 2.2 Overview of Models; 2.3 Role of Models in QbD; 2.3.1 CQA; 2.3.2 Risk Assessment; 2.3.3 Design Space; 2.3.4 Control Strategy; 2.4 General Scientific Considerations for Model Development.
|
| 505 |
8 |
|
|a 2.4.1 Models for Process Characterization2.4.2 Models for Supporting Analytical Procedures; 2.4.3 Models for Process Monitoring and Control; 2.5 Scientific Considerations for Maintenance of Models; 2.6 Conclusion; References; Chapter 3 Role of Automatic Process Control in Quality by Design ; 3.1 Introduction; 3.2 Design of Robust Control Strategies; 3.3 Some Example Applications of Automatic Feedback Control; 3.4 The Role of Kinetics Modeling; 3.5 Ideas for a Deeper QbD Approach; 3.6 Summary; Acknowledgments; References.
|
| 505 |
8 |
|
|a Chapter 4 Predictive Distributions for Constructing the ICH Q8 Design Space 4.1 Introduction; 4.2 Overlapping Means Approach; 4.3 Predictive Distribution Approach; 4.4 Examples; 4.4.1 A Mechanistic Model Example; 4.4.2 An Empirical Model Example; 4.5 Summary and Discussion; Acknowledgment; References; Chapter 5 Design of Novel Integrated Pharmaceutical Processes: A Model-Based Approach ; 5.1 Introduction; 5.2 Problem Description; 5.2.1 Mathematical Formulation; 5.2.2 Solution Approach; 5.3 Methodology; 5.3.1 Superstructure; 5.3.2 Model Development; 5.3.3 Decomposition Strategy.
|
| 505 |
8 |
|
|a 5.4 Application: Case Study5.4.1 Stage 1: Problem Definition; 5.4.2 Stage 2: Data/Information Collection/Analysis; 5.4.3 Stage 3: Superstructure, Model Development, and Decomposition Strategy; 5.4.4 Stage 4: Generation of Feasible Candidates and Screening; 5.4.5 Stage 5: Screening by Process Model; 5.4.6 Stage 6: Evaluation of the Feasible Options: Calculation of the Objective Function; 5.5 Conclusions; References; Chapter 6 Methods and Tools for Design Space Identification in Pharmaceutical Development ; 6.1 Introduction; 6.2 Design Space: A Multidisciplinary Concept.
|
| 505 |
8 |
|
|a 6.3 Integration of Design Space and Control Strategy6.4 Case Studies; 6.4.1 Design Space of a Continuous Mixer: Use of Data-Driven-Based Approaches; 6.4.2 Roller Compaction Case Study: Integration of Control Strategy and Its Effects on the Design Space; 6.4.2.1 Deterministic Design Space; 6.4.2.2 Stochastic Design Space; 6.4.2.3 Effect of Control Strategies on the Design Space; 6.5 Conclusions; Acknowledgment; References; Chapter 7 Using Quality by Design Principles as a Guide for Designing a Process Control Strategy ; 7.1 Introduction.
|
| 500 |
|
|
|a 7.2 Chemical Sequence, Impurity Formation, and Control Strategy.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|x Quality control.
|
| 650 |
|
7 |
|a Pharmaceutical industry
|x Quality control
|2 fast
|
| 700 |
1 |
|
|a Seymour, Christine.
|
| 700 |
1 |
|
|a Garc?a-Munoz, Salvador.
|
| 758 |
|
|
|i has work:
|a Comprehensive quality by design for pharmaceutical product development and manufacture (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCG6ycmFBV3gWyBdqtKcbbb
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Reklaitis, Gintaras.
|t Comprehensive Quality by Design for Pharmaceutical Product Development and Manufacture.
|d New York : American Institute of Chemical Engineers, ©2017
|z 9780470942376
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=5015542
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|